Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Next Issue
Volume 69, December
Previous Issue
Volume 69, June
 
 

Acta Microbiol. Hell., Volume 69, Issue 3 (September 2024) – 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
8 pages, 713 KiB  
Review
Clostridioides difficile Infection-Related Hepatic Abscess: A Review of the Literature
by Tahne Vongsavath, Magnus Chun, Kyaw Min Tun and Vignan Manne
Acta Microbiol. Hell. 2024, 69(3), 204-211; https://doi.org/10.3390/amh69030019 - 20 Sep 2024
Viewed by 423
Abstract
Hepatic abscesses (HAs) are suppurative cavities caused by the infiltration of liver parenchyma by microbes. The etiology of HAs can include biliary disease, intra-abdominal infections, bile duct ischemia following pancreaticoduodenectomy, liver transplantation, and rarely septicemia, among others. While HA of a bacterial origin [...] Read more.
Hepatic abscesses (HAs) are suppurative cavities caused by the infiltration of liver parenchyma by microbes. The etiology of HAs can include biliary disease, intra-abdominal infections, bile duct ischemia following pancreaticoduodenectomy, liver transplantation, and rarely septicemia, among others. While HA of a bacterial origin is rare, intra-abdominal biliary infections can be seen after appendicitis or proctitis. Empiric treatment generally involves antibiotic coverage and percutaneous drainage. Due to a high health care association, Clostridioides difficile infection (CDI) is becoming more frequent and has increasing antibiotic resistance. While generally limited to the gastrointestinal tract, extra intestinal CDIs are generally related to bacteremia, and related HAs are even rarer, with their prognostic courses not well described. A literature search was performed evaluating case reports and manuscripts relating to CDI-related HA. Articles with relevant information were analyzed for quality. Those fitting predetermined selection criteria and the level of evidence were included in this study. While most affected patients reported recent hospitalization and significant comorbidities, some of them reported no apparent risk factors at all. While all included individuals had HA, only 33.3% had CD-related bacteremia. Treatment of HA was managed with drainage as well as antibiotics and was generally successful, with one death. As CDI becomes more prevalent, studies such as this will be needed to address the management of associated HA. Full article
(This article belongs to the Special Issue Feature Papers in Medical Microbiology in 2024)
Show Figures

Figure 1

17 pages, 1119 KiB  
Review
Clinical and Ocular Inflammatory Inhibitors of Viral-Based Gene Therapy of the Retina
by Marc Ohlhausen and Christopher D. Conrady
Acta Microbiol. Hell. 2024, 69(3), 187-203; https://doi.org/10.3390/amh69030018 - 11 Sep 2024
Viewed by 667
Abstract
Gene therapy is an emerging field of medicine that can target and treat previously untreatable blinding or lethal diseases. Within the field of ophthalmology, gene therapy has emerged to treat retinal degenerative disorders, but its exact role is in its infancy. While this [...] Read more.
Gene therapy is an emerging field of medicine that can target and treat previously untreatable blinding or lethal diseases. Within the field of ophthalmology, gene therapy has emerged to treat retinal degenerative disorders, but its exact role is in its infancy. While this exciting frontier is rapidly expanding, these typically viral-based gene therapy vectors trigger a host immune response. Thus, a better understanding of the host immune response to gene therapies is critical, in that harnessing immunity to these vectors may improve treatment efficacy and reduce the risk of vision loss from inflammation. As such, we will discuss innate and adaptive immunity to gene therapy vectors, and avenues through which this response may be harnessed to improve visual outcomes. Full article
(This article belongs to the Special Issue Feature Papers in Medical Microbiology in 2024)
Show Figures

Figure 1

7 pages, 713 KiB  
Brief Report
Anti-HIV Activity of Philippine Crocodile (Crocodylus mindorensis) Serum on Infected Human Mononuclear Cells
by Alfredo A. Hinay, Jr., Nelyn Mae T. Cadotdot, Marilou V. Tablizo and Aprilyn F. Francisco
Acta Microbiol. Hell. 2024, 69(3), 180-186; https://doi.org/10.3390/amh69030017 - 7 Aug 2024
Viewed by 855
Abstract
The search for effective inhibitors of HIV-1 replication remains a critical research area of research in virology and immunology. Natural products have emerged as promising candidates for antiviral therapies. In the present study, we assessed the potential inhibitory activity of Philippine crocodile serum [...] Read more.
The search for effective inhibitors of HIV-1 replication remains a critical research area of research in virology and immunology. Natural products have emerged as promising candidates for antiviral therapies. In the present study, we assessed the potential inhibitory activity of Philippine crocodile serum at both pre- and post-infection stages of the HIV-1 replication cycle. Freshly collected crocodile serum samples were used in a cell culture-based assay with peripheral blood mononuclear cells. HIV-1 reverse transcriptase activity in the treated cell culture system was assessed using colorimetric enzyme immunoassay. The crocodile serum at 0.5% and 0.25% vol/vol concentrations showed an inhibitory activity against HIV-1 replication both in pre-infection interactions (68.61 ± 1.67% and 69.95 ± 2.24%, respectively) and post-infection interactions (65.68 ± 2.93% and 69.92 ± 0.45%, respective). These findings suggest that Philippine crocodile serum may have potential as a natural inhibitor of HIV-1 replication and warrant further investigation into its therapeutic use. Full article
Show Figures

Figure 1

13 pages, 3089 KiB  
Review
Exploring Bacteriophage Applications in Medicine and Beyond
by Ahmed Elfadadny, Rokaia F. Ragab, Manar A. Abou Shehata, Medhat R. Elfadadny, Ahmed Farag, Ayman H. Abd El-Aziz and Hazim O. Khalifa
Acta Microbiol. Hell. 2024, 69(3), 167-179; https://doi.org/10.3390/amh69030016 - 8 Jul 2024
Viewed by 2763
Abstract
Bacteriophages, or phages, are microscopic viruses that specifically infect and replicate within bacterial hosts. Their unique ability to target and control bacterial populations makes them valuable tools with applications ranging from human medicine and agriculture and environmental management to biotechnology. In this comprehensive [...] Read more.
Bacteriophages, or phages, are microscopic viruses that specifically infect and replicate within bacterial hosts. Their unique ability to target and control bacterial populations makes them valuable tools with applications ranging from human medicine and agriculture and environmental management to biotechnology. In this comprehensive review, we explore the diverse and promising medical and non-medical applications of bacteriophages, highlighting their pivotal role across various niches. From safeguarding food production through pathogen control to their innovative utilization in wastewater treatment, bacteriophages prove to be versatile agents. To achieve applications of phages on a larger scale, it is necessary to make the legal framework more suitable and flexible, create special approval programs (e.g., for novel antimicrobial drugs), and promote targeted research and development activities on phages. Additionally, a more intensive exchange between academia, industry, regulatory authorities, and stakeholders in the health system should be pursued. Full article
(This article belongs to the Special Issue Feature Papers in Medical Microbiology in 2024)
Show Figures

Figure 1

14 pages, 612 KiB  
Review
Combating Malaria with Vaccines: Insights from the One Health Framework
by Henry Sutanto
Acta Microbiol. Hell. 2024, 69(3), 153-166; https://doi.org/10.3390/amh69030015 - 5 Jul 2024
Viewed by 711
Abstract
Malaria remains a leading cause of morbidity and mortality worldwide, with significant efforts directed towards developing effective vaccines to curb its impact. The One Health concept, recognizing the interconnectedness of human, animal, and environmental health, offers a comprehensive approach to understanding and combating [...] Read more.
Malaria remains a leading cause of morbidity and mortality worldwide, with significant efforts directed towards developing effective vaccines to curb its impact. The One Health concept, recognizing the interconnectedness of human, animal, and environmental health, offers a comprehensive approach to understanding and combating this disease. This review examines the development of malaria vaccine through the lens of the One Health framework, highlighting the integration of human, vector, and environmental factors in the fight against malaria. We discuss the current landscape of malaria vaccine development, including the deployment of the RTS,S/AS01 vaccine and the progress of other candidates such as the R21/Matrix-M and PfSPZ vaccine. The challenges posed by the complex lifecycle of the malaria parasite, its genetic diversity, and the environmental factors influencing transmission are explored. This review also discusses emerging technologies and innovations that could enhance vaccine efficacy and delivery. Additionally, we consider ethical, social, and economic factors critical to the successful implementation of vaccination programs. In concluding, this review underscores the importance of adopting a One Health approach to malaria vaccine development, advocating for integrated efforts to address the multifaceted challenges of malaria control and eradication. Full article
Show Figures

Figure 1

9 pages, 1776 KiB  
Communication
Assembly and Annotation of the Complete Genome Sequence of the Paenibacillus Bacteriophage phJNUCC32
by Yang Xu, Xuhui Liang and Chang-Gu Hyun
Acta Microbiol. Hell. 2024, 69(3), 144-152; https://doi.org/10.3390/amh69030014 - 5 Jul 2024
Viewed by 632
Abstract
A potential biocontrol agent for American foulbrood (AFB), the Paenibacillus bacteriophage phJNUCC32, was isolated from Baengnokdam in Halla Mountain. This study aimed to investigate its genomic characteristics through whole-genome sequencing. The genome of phJNUCC32 was found to be 62,871 base pairs in length, [...] Read more.
A potential biocontrol agent for American foulbrood (AFB), the Paenibacillus bacteriophage phJNUCC32, was isolated from Baengnokdam in Halla Mountain. This study aimed to investigate its genomic characteristics through whole-genome sequencing. The genome of phJNUCC32 was found to be 62,871 base pairs in length, with a G + C content of 51.98%. Phylogenetic analysis classified phJNUCC32 within the unclassified Caudoviricetes bacteriophage category. The genome prediction confirmed the absence of virulence factors and antibiotic-resistance genes, ensuring its genetic safety. A total of 63 coding DNA sequences were identified, revealing a modular arrangement. Notably, the annotation of gene function indicates that phJNUCC32 harbors the holin/lysin system, suggesting significant potential for controlling bacterial infections in AFB and agriculture. Full article
Show Figures

Figure 1

2 pages, 163 KiB  
Editorial
The Value of a “One Health” Approach—The Updated Scope of Acta Microbiologica Hellenica
by Athanasios Tsakris
Acta Microbiol. Hell. 2024, 69(3), 142-143; https://doi.org/10.3390/amh69030013 - 4 Jul 2024
Viewed by 691
Abstract
The COVID-19 pandemic has challenged the resilience of public health sectors worldwide [...] Full article
Previous Issue
Next Issue
Back to TopTop